Institutional Ownership
Gt Biopharma Inc
CUSIP 36254L308COMGTBPQ1 2026
13D / 13G Filings
4
Schedule 13D/13G on record
Beneficial Filers
4
Distinct reporting persons
Largest Stake
19.8%
Max % of class reported
Institutional Holders
39
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
4 filings · latest Jun 2, 2025
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Geode Capital Management, LLC | 294.5K | $120.2K |
| 2 | Arax Advisory Partners | 93.6K | $38.2K |
| 3 | Citadel Advisors LLC | 66.2K | $27.0K |
| 4 | Seacrest Wealth Management, LLC | 50.0K | $20.4K |
| 5 | Ubs Group AG | 46.0K | $18.8K |
| 6 | Two Sigma Securities, LLC | 31.8K | $13.0K |
| 7 | Lpl Financial LLC | 30.4K | $12.4K |
| 8 | Invst, LLC | 23.4K | $9.6K |
| 9 | Osaic Holdings, Inc. | 21.0K | $8.6K |
| 10 | Cerity Partners LLC | 20.0K | $8.2K |